Literature DB >> 1721489

L and H cells of nodular lymphocyte predominant Hodgkin's disease show immunoglobulin light-chain restriction.

C Schmid1, C Sargent, P G Isaacson.   

Abstract

The nodular form of lymphocyte predominant Hodgkin's disease (NLPHD) is widely accepted to be a B-cell-derived neoplasm. Despite this consensus, previous studies have not shown monotypic immunoglobulin (Ig) light-chain expression by the putatively malignant L & H cells. We have studied paraffin-embedded tissue from 19 cases of NLPHD for the presence of Ig light and heavy chains and J chain. In addition, frozen tissue, available from one case, was examined with antibodies to light chains. In paraffin material, in each case L & H cells in individual nodules were examined for the presence of Ig light chain restriction. Kappa-light-chain restriction was detected in all L & H cells in all nodules in 5/19 cases (26.5%) and this was confirmed in frozen sections available from one case. Of the remaining 14 cases, 13 (68.5%) showed kappa-light-chain restriction in a proportion of nodules and in 1 case light-chain restriction was not observed. Of 14 cases stained with antibodies to Ig heavy chains 13 contained IgG, and in 1 case no heavy chains were demonstrable. Most L & H cells in 15 cases examined contained J chain. Our finding of monotypic L & H cells in NLPHD in 95% of our investigated cases provides strong evidence for the neoplastic nature of L & H cells and supports the hypothesis that NLPHD is a malignant nonHodgkin's B-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721489      PMCID: PMC1886478     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Immunoglobulin in Reed-Sternberg and Hodgkin cells.

Authors:  R C Curran; E L Jones
Journal:  J Pathol       Date:  1978-09       Impact factor: 7.996

2.  Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution.

Authors:  S M Chittal; C Alard; J F Rossi; T al Saati; A Le Tourneau; J Diebold; G Delsol
Journal:  Am J Surg Pathol       Date:  1990-11       Impact factor: 6.394

Review 3.  Immunogenotyping in Hodgkin's disease.

Authors:  H Griesser; T W Mak
Journal:  Hematol Oncol       Date:  1988 Jul-Sep       Impact factor: 5.271

4.  Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy?

Authors:  J T Sundeen; J Cossman; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1988-08       Impact factor: 6.394

5.  Absence of B-cell or T-cell clonal expansion in nodular, lymphocyte predominant Hodgkin's disease.

Authors:  M D Linden; A J Fishleder; W E Katzin; R R Tubbs
Journal:  Hum Pathol       Date:  1988-05       Impact factor: 3.466

6.  Lymphocyte predominant Hodgkin's disease of nodular subtype combined with pulmonary lymphoid infiltration and hypogammaglobulinaemia.

Authors:  G Li; M L Hansmann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.

Authors:  G S Pinkus; J W Said
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

8.  Predominant expression of lambda light chain in adult cases with non-T-cell acute lymphocytic and chronic myelogenous leukemia in lymphoid blast crisis.

Authors:  N Mori; K Oka; Y Yoda; T Abe; M Kojima
Journal:  Cancer       Date:  1991-08-15       Impact factor: 6.860

9.  Demonstration of intracytoplasmic immunoglobulin in non-T-acute lymphocytic leukemia cases of children with immunoelectron microscopic examination.

Authors:  N Mori; K Oka; T Hanada; A Iizuka; M Kojima
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

10.  Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction.

Authors:  J W Said; A F Sassoon; I P Shintaku; P J Kurtin; G S Pinkus
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

View more
  8 in total

1.  A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma.

Authors:  Kati Kiil; Julia Bein; Bianca Schuhmacher; Lorenz Thurner; Markus Schneider; Martin-Leo Hansmann; Sylvia Hartmann
Journal:  Virchows Arch       Date:  2018-09-26       Impact factor: 4.064

Review 2.  [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].

Authors:  S Hartmann; S Cogliatti; M-L Hansmann
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

3.  Lymphocyte predominance Hodgkin's disease. Evidence for a kappa light chain-restricted monotypic B-cell neoplasm.

Authors:  M H Stoler; G E Nichols; M Symbula; L M Weiss
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

4.  Poor correlation between clonal immunoglobulin gene rearrangement and immunoglobulin gene transcription in Hodgkin's disease.

Authors:  Y Yatabe; K Oka; J Asai; N Mori
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

5.  Colliding / concomitant tumors of the intestine: report of 3 cases.

Authors:  Sebastian Mannweiler; Hans Peter Dinges; Christine Beham-Schmid; Hubert Hauser; Michael Starlinger; Sigrid Regauer
Journal:  Pathol Oncol Res       Date:  2003-10-07       Impact factor: 3.201

Review 6.  Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.

Authors:  Lorenz Thurner; Sylvia Hartmann; Frank Neumann; Markus Hoth; Stephan Stilgenbauer; Ralf Küppers; Klaus-Dieter Preuss; Moritz Bewarder
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

7.  p53 expression in Reed-Sternberg cells of Hodgkin's disease.

Authors:  R K Gupta; A J Norton; I W Thompson; T A Lister; J G Bodmer
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

8.  Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?

Authors:  Sylvia Hartmann; Claudia Döring; Christina Jakobus; Benjamin Rengstl; Sebastian Newrzela; Thomas Tousseyn; Xavier Sagaert; Maurilio Ponzoni; Fabio Facchetti; Chris de Wolf-Peeters; Christian Steidl; Randy Gascoyne; Ralf Küppers; Martin-Leo Hansmann
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.